Target
Galectin-8
Ligand
BDBM50509533
Substrate
n/a
Meas. Tech.
ChEMBL_1838661 (CHEMBL4338794)
Kd
98000±n/a nM
Citation
 Mahanti, MPal, KBSundin, APLeffler, HNilsson, UJ Epimers Switch Galectin-9 Domain Selectivity: 3 ACS Med Chem Lett 11:34-39 (2020) [PubMed]  Article 
Target
Name:
Galectin-8
Synonyms:
Gal-8 | LEG8_HUMAN | LGALS8 | PCTA-1 | Po66 carbohydrate-binding protein | Po66-CBP | Prostate carcinoma tumor antigen 1
Type:
PROTEIN
Mol. Mass.:
35814.23
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1454625
Residue:
317
Sequence:
MMLSLNNLQNIIYNPVIPFVGTIPDQLDPGTLIVIRGHVPSDADRFQVDLQNGSSMKPRADVAFHFNPRFKRAGCIVCNTLINEKWGREEITYDTPFKREKSFEIVIMVLKDKFQVAVNGKHTLLYGHRIGPEKIDTLGIYGKVNIHSIGFSFSSDLQSTQASSLELTEISRENVPKSGTPQLRLPFAARLNTPMGPGRTVVVKGEVNANAKSFNVDLLAGKSKDIALHLNPRLNIKAFVRNSFLQESWGEEERNITSFPFSPGMYFEMIIYCDVREFKVAVNGVHSLEYKHRFKELSSIDTLEINGDIHLLEVRSW
  
Inhibitor
Name:
BDBM50509533
Synonyms:
CHEMBL4557916
Type:
Small organic molecule
Emp. Form.:
C19H21Cl2NO5S
Mol. Mass.:
446.345
SMILES:
COc1cccc(N[C@H]2[C@@H](O)[C@@H](CO)O[C@H](Sc3ccc(Cl)c(Cl)c3)[C@@H]2O)c1 |r|
Structure:
Search PDB for entries with ligand similarity: